Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United States

Diagnostic Microbiology and Infectious Disease

Volumn 21, Issue 2, 1995, Pages 85-93

  Jones, Ronald N ^a   Sader, Helio S ^a   Erwin, Meridith E ^a   Anderson, Steven C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINAFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; KANAMYCIN; NOVOBIOCIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; SPECTINOMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; TROSPECTOMYCIN; VANCOMYCIN;

ARTICLE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

ANTIBIOTICS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; PREVALENCE; UNITED STATES;

EID: 0029067628     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/0732-8893(94)00147-O     Document Type: Article

References (42)

1. Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256
2. Genetics and mechanism of glycopeptide resistance in enterococci
3. Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests
4. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci
5. High-level penicillin resistance among isolates of enterococci: implications for treatment of enterococcal infections
6. Nosocomial enterococci resistant to vancomycin: United States, 1989–1993: National Nosocomial Infection Surveillance
7. Loss of synergy in enterococcal isolates with resistance to ampicillin and vancomycin [abstr 248]
8. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria
9. Increasing problems in the therapy of enterococcal infections
10. In vivo antibiotic synergism: contribution of animal models
11. Mechanisms of resistance of enterococci to beta-lactam antibiotics
12. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States
13. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one instiution
14. In vivo development of teicoplanin resistance in a van B Enterococcus faecium isolate
15. Controversies and confusion regarding antimicrobial susceptibility testing of enterococci
16. Accuracy of the Etest for determining antimicrobial susceptibilities of staphylococci enterococci Campylobacter jejuni and Gram-negative bacteria resistant to antimicrobial agents
17. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
18. Vancomycin resistance gene van C is specific to Enterococcus gallinarum
19. Emergence of enterococcus as a significant pathogen
20. The life and times of the enterococcus
21. β-Lactamase-producing enterococci
22. Ampicillin-resistant enterococcal species in an acute-care hospital
23. Time-kill kinetic studies of ampicillin/sulbactam for β-lactamase-producing enterococci
24. Rapid dissemination of β-lactamase-producing aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward
25. Chromosomally mediated β-lactamase production and gentamicin resistance in Enterococcus faecalis
26. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
27. The Etest applied to susceptibility tests of gonococci, multiply resistant enterococci, and Enterobacteriaceae producing potent beta-lactamases
28. Use of the Etest to predict high-level resistance to aminoglycosides among enterococci
29. Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?
30. Reliability of the Etest for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp
31. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256
32. Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin
33. Problems with the disk diffusion test for detection of vancomycin resistance in enterococci
34. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci
35. Vancomycin-resistant enterococci
36. Antimicrobial susceptibilities of enterococci isolated from hospitalized patients
37. Vancomycin susceptibility and identification of motile enterococci
38. Detection of vancomycin resistance in Enterococcus species
39. Inducible resistance to vancomycin in Enterococcus faecium D366
40. Induction of tolerance in nontolerant lytic strains of S. faecalis from the Solomon Island [abst 1027]